Loading...
XSTO
HEART
Market cap10mUSD
, Last price  
SEK
Name

Scandinavian Real Heart AB

Chart & Performance

D1W1MN
XSTO:HEART chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
70.54%
Rev. gr., 5y
%
Revenues
0k
1210443226,257148,054132,674774,967111,34700010,000000
Net income
-35m
L+3.34%
-116,791-86,595-13,469-258,000-1,690,000-1,531,000-3,884,000-13,744,000-8,858,000-7,290,000-8,821,000-10,483,000-13,988,000-67,977,000-34,350,000-35,496,149
CFO
-16m
L+20.56%
-1,766,296-1,399,430-3,489,767-9,859,044-6,447,558-7,322,359-9,411,175-9,652,923-7,380,149-25,050,172-12,992,551-15,663,853

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Scandinavian Real Heart AB (Publ), a Swedish enterprise established in 2007, specializes in the innovation and production of artificial heart devices. The company's core focus is the Realheart TAH, a total artificial heart engineered specifically to address severe cases of heart failure. Beyond this central project, their product portfolio also encompasses medical solutions such as the RealVAD, PulsePump, and Sternal Prosthesis. The firm operates from its base in Västerås, Sweden.
URL
https://realheart.se/
IPO date
Nov 26, 2014
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT